Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Journal of Surgical Oncology|August 12, 2016
Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy considerationJee Suk Chang, Kyung Hwan Kim, Ki Chang Keum, et al.
Cancer Research and Treatment|February 20, 2019
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in KoreaHyo Song Kim, Chung Mo Nam, Suk-Yong Jang, et al.
The AAPS Journal|May 31, 2018
A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyDongwoo Chae, Chung Mo Nam, Joo Hoon Kim, et al.
Oncology|August 11, 2011
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profilesHyo Song Kim, Min Hee Hong, Kiyeol Kim, et al.
Annals of Surgical Oncology|June 22, 2010
The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-upMinkyu Jung, Hyun Joon Shin, Sun Young Rha, et al.
Oncotarget|April 19, 2017
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumabChoong-Kun Lee, Seung-Seob Kim, Saemi Park, et al.
Urologic Oncology|November 4, 2008
Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapyHyo Song Kim, Won Seog Kim, Se Hoon Park, et al.
Oncotarget|November 8, 2017
Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancerKohei Shitara, Tae Min Kim, Tomoya Yokota, et al.
BMC Cancer|June 30, 2009
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapyHyo Song Kim, Jeeyun Lee, Seong Yoon Yi, et al.
Cancer Research and Treatment|January 22, 2011
Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sitesJoo Hoon Kim, Sun Young Rha, Chan Kim, et al.
Pageof 13